Biomerica, Inc. (NASDAQ:BMRA) Short Interest Up 89.1% in September

Biomerica, Inc. (NASDAQ:BMRA) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totaling 219,400 shares, an increase of 89.1% from the August 31st total of 116,000 shares. Approximately 8.5% of the company’s stock are sold short. Based on an average daily volume of 797,900 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 797,900 shares, the short-interest ratio is currently 0.3 days. Approximately 8.5% of the company’s stock are sold short.

Biomerica Trading Up 4.6%

NASDAQ:BMRA opened at $2.93 on Tuesday. The stock has a market capitalization of $8.41 million, a PE ratio of -1.26 and a beta of 0.34. Biomerica has a 1-year low of $2.08 and a 1-year high of $10.16. The firm has a fifty day simple moving average of $3.05 and a 200 day simple moving average of $3.42.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Biomerica in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Biomerica stock. Bulltick Wealth Management LLC acquired a new stake in Biomerica, Inc. (NASDAQ:BMRA) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 137,149 shares of the company’s stock, valued at approximately $78,000. Bulltick Wealth Management LLC owned about 5.39% of Biomerica as of its most recent SEC filing. 22.28% of the stock is currently owned by hedge funds and other institutional investors.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.